Cargando…
Cytotoxicity of VEGF(121)/rGel on vascular endothelial cells resulting in inhibition of angiogenesis is mediated via VEGFR-2
BACKGROUND: The fusion protein VEGF(121)/rGel composed of the growth factor VEGF(121 )and the plant toxin gelonin targets the tumor neovasculature and exerts impressive anti-vascular effects. We have previously shown that VEGF(121)/rGel is cytotoxic to endothelial cells overexpressing VEGFR-2 but no...
Autores principales: | Mohamedali, Khalid A, Ran, Sophia, Gomez-Manzano, Candelaria, Ramdas, Latha, Xu, Jing, Kim, Sehoon, Cheung, Lawrence H, Hittelman, Walter N, Zhang, Wei, Waltenberger, Johannes, Thorpe, Philip E, Rosenblum, Michael G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176242/ https://www.ncbi.nlm.nih.gov/pubmed/21849059 http://dx.doi.org/10.1186/1471-2407-11-358 |
Ejemplares similares
-
Treatment of acute lymphoblastic leukemia with an rGel/BLyS fusion toxin
por: Parameswaran, Reshmi, et al.
Publicado: (2012) -
Targeting of Tumor Neovasculature with GrB/VEGF(121), a Novel Cytotoxic Fusion Protein
por: Mohamedali, Khalid A., et al.
Publicado: (2017) -
Multi-Modality Therapeutics with Potent Anti-Tumor Effects: Photochemical Internalization Enhances Delivery of the Fusion Toxin scFvMEL/rGel
por: Selbo, Pål K., et al.
Publicado: (2009) -
Photochemical activation of MH3-B1/rGel: a HER2-targeted treatment approach for ovarian cancer
por: Bull-Hansen, Bente, et al.
Publicado: (2015) -
Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression
por: Wang, Min, et al.
Publicado: (2019)